Ayass BioScience, LLC
Ramya Ramankutty Nair is a researcher with extensive experience in environmental microbiology and biotechnology. Currently employed at Ayass BioScience, LLC since September 2021, Ramya focuses on developing and validating panels for multi-color flow cytometry assays and multiplex Luminex assays. Previously, at the National Centre for Aquatic Animal Health (NCAAH) from May 2011 to June 2017, Ramya conducted significant research on ammonia-oxidizers in bioaugmented zero water exchange shrimp ponds and studied environmental factors affecting their specialization, including physicochemical characterization of water and sediment and constructing a sequence-based library of ammonia-oxidizers. Ramya holds a Doctor of Philosophy in Environmental Microbiology and Biotechnology from Cochin University of Science and Technology, as well as a Master's degree in Biotechnology from RVS College of Arts and Science and a Bachelor's degree in Biotechnology from St. Joseph's College.
This person is not in any teams
Ayass BioScience, LLC
Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcome by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, and next generation sequencing. Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. Our goal is to help clinicians implement unique precision medicine in their daily practice. Ayass BioScience, LLC (DBA as Ayass Lung Clinic, PLLC) is a CLIA certified laboratory performing advanced Next Generation Sequencing (Genetic Testing), Cardiac Conditions Hereditary Risk Assessment, Hereditary Cancer Risk Assessment, Neurological Conditions Genetic Predisposition Testing, also COVID-19 Testing (COVID-19 SARS-CoV-2 by RT-PCR), Pharmacogenetic Testing, Allergen Component-Resolved Testing, and Innovative Laboratory Testing. Ayass BioiScience, LLC is working on Aptamers Research and Testing. Ayass BioScience, LLC aims to be at the forefront of latest advancements in precision medicine to provide you with the most effective prevention and treatment options possible.